Drawing for HITKIT

USPTO serial 90346293

HITKIT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, CAMERON L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HITKIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

George Likourezos

George Likourezos CARTER, DELUCA & FARRELL LLP576 BROAD HOLLOW ROADMELVILLE, NY 11747United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, a partial agonist of N-methyl-D-aspartame (NMDA) receptors at low dose and a partial antagonist of NMDA at high dose, an inhibitor of microglial activation, and a modulator of NMDA receptors; antibiotics; pharmaceuticals and antibiotics for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; pharmaceuticals and antibiotics for reversing the damage caused by concussion or traumatic brain injuryACTIVE—
010Drug delivery system, namely, an intramuscular autoinjector and an intramuscular drug delivery autoinjector; drug delivery system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury, namely, an intramuscular autoinjector, and an intramuscular needle-based injection system; an intramuscular needle-based injection system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; drug delivery system for reversing the damage caused by concussion or traumatic brain injury, namely, intramuscular autoinjector and an intramuscular needle-based injection systemACTIVE—
035Retail store services featuring drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injuryACTIVE—
044Medical services, namely, providing medical services using drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injuryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 2, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 2, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 11, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 30, 2024EX4GSOU EXTENSION 4 GRANTED—
Jan 30, 2024EXT4SOU EXTENSION 4 FILED—
Jan 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 26, 2023EX3GSOU EXTENSION 3 GRANTED—
Jul 26, 2023EXT3SOU EXTENSION 3 FILED—
Jul 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 26, 2023EX2GSOU EXTENSION 2 GRANTED—
Jan 26, 2023EXT2SOU EXTENSION 2 FILED—
Jan 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 14, 2022EX1GSOU EXTENSION 1 GRANTED—
Jul 14, 2022EXT1SOU EXTENSION 1 FILED—
Jul 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 12, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 12, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 12, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 12, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 12, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 12, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 12, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 12, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 20, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2021DOCKASSIGNED TO EXAMINER—
Feb 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 7, 2020TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 7, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 2, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance